ImmunoTX Summit 2017

ImmunoTX Summit is organized by Global Technology Community (GTC) and would be held during Feb 6 - 7, 2017 at Hard Rock Hotel San Diego, San Diego, California, United States of America.

They invite you to GTCbio's ImmunoTX Summit, which takes place on February 6-7, 2017 in San Diego, CA. The summit will bring together their usual balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the various topics below.

15th Cytokines & Inflammation :
This conference has become an established meeting point for academic scientists, industry clinical developers, and government researchers to discuss complementary approaches in the field of cytokine biology. Some focused topics we will discuss include developments in the therapeutic application of cytokines and proposal of new targets, the complex relationship between the immune system and microbes in the homeostasis of mucosal tissues, novel means to modulate immune pathways to promote anti-tumor activity, and many more.

9th Immunotherapeutics & Immunomonitoring :
Leading experts from the scientific and clinical arenas and industry will present novel findings and developments in the constantly-changing area of immunological assays and procedures. They will also discuss recent advances in immunotherapy as they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment. Potential clinical feasibility and commercial potential of the newest data obtained from leading biomedical research laboratories will also be discussed.

5th Immunogenicity & Immunotoxicity :
We will provide guests with a better understanding of the ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins. Guests will get an up-to-date understanding of the mechanisms and consequences of protein aggregation and insights on how to prosecute state-of-the-art assessment of the clinical immunogenicity of therapeutic proteins.

The immune system plays a central role not only in fighting infections, but also in many diseases and medical conditions, including cancer. Studies of the immune system has led to significant findings in many fields of medicine and biology, which has yielded the discovery of novel and unique substances and reagents that are now widely used for diagnosing, evaluating, and treating different malignant diseases. The development of prophylactic and therapeutic vaccines, and innovative combinatorial immunotherapeutic approaches, has substantially decreased mortality, increased life expectancy, improved life expectancy and improved the well-being of the millions of patients.